Our Products and Services

The breadth of our product and service offering is dictated by our belief that reimbursement is the single biggest challenge faced by medical companies today.

Thus, we’re intimately connected with the most up-to-date payer concerns and opinions through our Reimbursement Intelligence Network – an unparalleled network of 5,000 decision-makers from virtually all significant managed care organizations – representing Medicare, Medicaid and commercial plans. We talk with these decision-makers regularly, on behalf of our clients and for ourselves, to make sure we know exactly what they’re thinking.

But we also believe that reimbursement is far more than merely the access restrictions imposed by payers or the discounts they demand – as important as they may be.

Successfully commercializing innovation requires companies to navigate a complex network of forces – understanding, for example, how patients and physicians will react to payer-imposed restrictions or communicating to payers the value of innovation, or figuring out which endpoints in a development program are likeliest to appeal to payers, key opinion leaders (and opinion followers), and patients.

That’s why our products and services include …

  • Custom Market Research and Analytics on the reimbursement landscape and specific concerns likely to affect your product, product line or development-stage opportunities.
  • Rapid Response provides a real-time “pulse” with a panel of managed markets experts to obtain critical information for brand decision making and pipeline strategy.
  • Syndicated Reports reporting the insights from payers on their evolving thinking about the latest scientific developments in key therapeutic areas in order to understand how they’re likely to respond with access and cost controls to the newest therapies.
  • Training Programs for management and sales forces so they understand the reimbursement issues physicians and managed care executives care about most.
  • Managed Markets Communication – delivering the right messages about your products so that payers can understand its innovations and make it accessible to physicians and patients.

Reimbursement Intelligence Network

It’s not a product. And it’s not a service. But the Reimbursement Intelligence Network, or RIN, underlies much of the work we do – and keeps making us smarter about the world of managed markets. RIN is an extensively coded database of over 5,000 key decision makers in government and commercial health plans, integrated delivery systems, accountable care organizations (ACOs) and pharmacy benefit management companies. We’ve got all the people who directly make the formulary decisions – pharmacy directors, medical directors, but we’ve also got the people who are important influencers on access decisions, including office billing managers, hospital chief operating officers, quality improvement directors and case managers, employers and employee benefit consultants. We survey them regularly on behalf of our clients – and for ourselves. And because we talk to them so regularly, we’ve also learned how to talk to them: we know the right questions to ask to elicit actionable information, to get our clients closest to the truth about reimbursement, to what will happen to their product in the marketplace. And we also know which members of our RIN to talk with about your specific program: since the database is extensively coded, we can virtually instantly target the right RIN members. If your product is likely to be heavily used in a Medicaid population, for example, we’ll make sure we’re talking with RIN members who influence access in Medicaid – and that we’re not wasting your time (and coming up with misleading information) by surveying RIN members with no influence in that segment of the payer community.

The RI analytics team will focus on identifying the reimbursement landscape for the product or technology by speaking with members of the RIN, Reimbursement Intelligence Network. The RIN represents Managed Care experts from Medicare, Medicaid, and Commercial plans. We have the pulse of the market and have several unique services unparalleled in the industry. We have a database of more than 5,000 decision makers and can segment them based upon customer type, number of covered lives, demographics, or any other customized request.

CUSTOM MARKET RESEARCH AND ANALYTICS

Whether your product is in early stage development or nearing patent expiration, Reimbursement Intelligence can research and identify the critical challenges and opportunities it will face in today’s managed markets environment – and is likely to face in the very different environment that is rapidly evolving. (More info)

RAPID RESPONSE RESEARCH PANELS

Rapid Response delivers immediate answers to support informed decisions that have to be made in a hurry. Together with the client, we prepare a focused set of questions (perhaps 10-15) and send them to a select group of managed markets experts (up to 30) from our RIN database, then quickly gather and analyze the responses. Within 7-10 days, you’ll get an in-person presentation of a cogent report detailing the answers and, especially, the “so what”. (More info)

SYNDICATED REPORTS

Each year, we survey payers on their evolving thinking about the latest scientific developments in key therapeutic areas in order to understand how they’re likely to respond with access and cost controls to the newest therapies from the biopharma companies. In general, we deliver these reports after new clinical-trial data is released at national meetings including American Society of Clinicial Oncologists (ASCO), American Society of Hematology (ASH), American College of Rheumatology (ACR), American Academy of Neurology (AAN), Interscience Conference on Antimicrobial Agents (ICAAC) and Digestive Diseases Week (DDW). These reports give our clients a detailed understanding of likely formulary placement, response to clinical trial endpoints, pricing and impact on current treatment pathways. (More info)

REIMBURSEMENT TRAINING

Every day, your sales reps face reimbursement objections and questions from physicians and their staffs. No wonder. Increasingly, payers are loading more costs onto patients through greater co-payments and co-insurance benefit structures – and changing how physicians themselves are paid for physician-administered drugs. The sales rep’s job is no longer to merely explain a product’s benefits: he or she needs to explain the economic implications as well. And to do that, they need a far greater understanding of managed care than most have today. (More info)

MANAGED MARKETS COMMUNICATION

To maximize access and reimbursement, Reimbursement Intelligence partners with our clients to deliver payer communications with impact, messages and formats that inform and motivate these key customers.(More info)